| |
 Shire
is a rapidly growing global specialty pharmaceutical company.
We have a global sales and marketing infrastructure with a
broad portfolio of products and our own direct marketing capability
in the US, Canada, UK, Republic of Ireland, France, Germany,
Italy and Spain. We also cover the other significant pharmaceutical
markets indirectly through regional distributors. Shire's
interest in the Pacific Rim is managed through Shire's regional
office based in Singapore.
For the dermatological sector in Germany we have got two products
to offer: SOLARAZE™ (3%, gel diclofenac sodium
(3%w/w)) for the treatment of aktinic keratosis and VANIQA®
11.5% Cream (eflornithine) for the reduction of unwanted facial
hair in women.
|
|
